Mitigating inflammation using advanced drug delivery by targeting TNF-α in lung diseases

Oxidative stress-based therapeutics in COPD

(2020) Peter J. Barnes   Redox Biology

Tumor necrosis factor in lung cancer: Complex roles in biology and resistance to treatment

(2020) Ke Gong et al.   NEOPLASIA

Targeted Treatments for Chronic Obstructive Pulmonary Disease (COPD) Using Low-Molecular-Weight Drugs (LMWDs)

(2019) Huihui Ti et al.   JOURNAL OF MEDICINAL CHEMISTRY

Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases

(2019) Meenu Mehta et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Mesenchymal Stem Cell-Based Therapy of Inflammatory Lung Diseases: Current Understanding and Future Perspectives

(2019) C. Randall Harrell et al.   Stem Cells International

Recent advances in aerosol gene delivery systems using non-viral vectors for lung cancer therapy

(2019) Ah Young Lee et al.   Expert Opinion on Drug Delivery

Emerging trends in the novel drug delivery approaches for the treatment of lung cancer

(2019) Parvarish Sharma et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Exosomes in lung cancer diagnosis and treatment. From the translating research into future clinical practice

(2018) Christos Masaoutis et al.   BIOCHIMIE

Anti-TNFα therapy in inflammatory lung diseases

(2017) Rama Malaviya et al.   PHARMACOLOGY & THERAPEUTICS

siRNA-Based Therapies for Pulmonary Diseases

(2014) Uday Koli et al.   Journal of Biomedical Nanotechnology

Tumor Necrosis Factor Inhibitors and Lung Disease: A Paradox of Efficacy and Risk

(2009) Atul A. Khasnis et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM